HanAll Biopharma has received Orphan Drug Designation (ODD) from the Ministry of Health, Labor and W...
read moreIantrek Corporation has released promising results from its two-year clinical study on bio-reinforce...
read moreChina has approved SYCUME, the country’s first monoclonal antibody treatment for thyroid eye disease...
read moreStealth BioTherapeutics Inc. has achieved 50% of its enrollment target in the global Phase 3 ReNEW s...
read moreHarrow, a North American eyecare pharmaceuticals company, has introduced VEVYE Access For All, a new...
read moreA nationwide survey conducted by the Preservative Freedom Coalition highlights a critical gap in pat...
read moreTopcon Healthcare, RadiusXR, and Glaukos have announced a strategic collaboration to launch Inspire,...
read moreHarrow has finalized a 5-year strategic supply and development (SSD) agreement to ensure the continu...
read moreKodiak Sciences has successfully completed patient enrollment for its Phase 3 GLOW2 trial, evaluatin...
read more